Effective Treatments for Bladder Cancer Affecting CXCL9/CXCL10/CXCL11/ CXCR3 Axis: A Review
Effective Treatments for Bladder Cancer Affecting CXCL9/CXCL10/CXCL11/ CXCR3 Axis: A Review
About this item
Full title
Author / Creator
Publisher
Muscat - Oman: Oman Medical Specialty Board
Journal title
Language
English
Formats
Publication information
Publisher
Muscat - Oman: Oman Medical Specialty Board
Subjects
More information
Scope and Contents
Contents
Bladder cancer (BC) originates mainly from the epithelial compartment of the bladder,
which is defined as transitional cell carcinoma or urothelial cell carcinoma. About 70%
of patients with BC will survive five years from diagnosis. Previous studies revealed that
the immune system and its mediators, particularly chemokines, play a crucial...
Alternative Titles
Full title
Effective Treatments for Bladder Cancer Affecting CXCL9/CXCL10/CXCL11/ CXCR3 Axis: A Review
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7064791
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7064791
Other Identifiers
ISSN
1999-768X,2070-5204
E-ISSN
2070-5204
DOI
10.5001/omj.2020.21
